OLATHE, Kansas — Ronawk, innovators in stem cell expansion technologies, has launched a trial program to provide its patented tissue-blocks (T-Blocks) to commercial cell producers and regenerative medicine partners. Their T-Blocks are a 3D matrix consumable product that enable the stem cell industry by providing means to increase stem cell production by 3,600 times vs. traditional expansion methods. [Read more…]
Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank
CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world. By the end of 2020, CryoHoldco will be seven times larger than any other stem cell bank in Latin America and will have 275,000 stem cell units in storage.
Pivotal Trends Impacting the Global Cord Blood Industry in 2020
The cord blood industry came into existence in the early 1990’s with the formation of several cord blood banks in the U.S. and worldwide. It has also been almost 40 years since it was first proposed that stem and progenitor cells were present in human cord blood. [Read more…]
Biotech Investing: A List of Stem Cell Stocks from “A” to “Z”
Biotech investing has become an increasingly popular in recent years. Whether you’re new to biotech stocks or you’ve been around the block, with the recent stock market drops caused by COVID-19, now could be a good time to place your bets.
The stock market had its largest point drop in recent history on March 9, 2020. Shortly thereafter, on March 12 and March 16, there were two more record-setting point drops. Even though the market has recovered somewhat following the $2.2 trillion stimulus bill, market prices remain attractive across many sectors.
Furthermore, stem cell companies are receiving startling support for use of living therapeutics against COVID-19 induced respiratory complications, such as ARDS. The Australian company, Mesoblast, is now enrolling for a 300 person trial and the American company, Athersys, is enrolling for an even larger 400 person trial.
Under these conditions, one of the most intriguing niches within biotech investing is stem cell stocks. [Read more…]
Stem Cell Treatment Now Available in the UK, as LifePlus Stem Cells Launches in London
July 21, 2020 — LifePlus Stem Cells is the first Stem Cell service in the UK to provide doctors and prescribers with quantifiable, quality assured autologous and allogeneic stem cells, with appropriate HTA and MHRA licenses.
Patients in the UK can now benefit from Stem Cell treatments prescribed as a medicine, which can be used for a wide range of conditions. [Read more…]
